Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 31.29

-1.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron who wrote (356)	3/25/1998 2:50:00 PM
From: Eric M.	Read Replies (1) of 455

Paramount Capital is doing a private placement at $0.50 per share. Paramount does these deals where they take biotech companies that are down and out, put some money in it and reorganize it with new management and maybe some additional in-licensed technology. Then they do a private placement, and then tout the hell out of the stock (I do not know exactly how). These companies are usually very good performers for the first few months after the deal closes. Look at ATLC and ENDR. These Paramount deals closed in July and October of 1997, respectively. The Procept deal closes next week and I would anticipate significant upward price movement in the next few months.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next